Compare Adaptive Biotechnologies Corp (ADPT) vs Amplitude Inc (AMPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Amplitude Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Amplitude Inc trades at $12.78 (market cap $1.59B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2.5× Amplitude Inc's market cap. Which is the better fit depends on your goals.
| ADPT | AMPL | |
|---|---|---|
Market Cap | $4.04B | $1.59B |
Sector | Health | Technology |
52-Week High | $25.45 | $12.69 |
52-Week Low | $12.30 | $5.61 |
Enterprise Value | $4.10B | $1.45B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Amplitude Inc
Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.
Read more on AMPL →
